Simcere Pharmaceutical Group.
No 699-18 Xuan Wu Avenue
Xuan Wu District
Nanjing,
210042
China - Map
Phone: 86 25 8556 6666
Fax: 86 25 8547 1729
Web Site: http://www.simcere.com
| Simcere Pharmaceutical Group engages in the research, development, manufacture, distribution, and marketing of branded generic pharmaceutical products in the Peoples Republic of China. Its principal products include prescription edaravone injection for the treatment of strokes under the Bicun brand; amoxicillin capsules, dispersible tablets, granules, and injection under the brand Zailin; and generic diclofenac sodium, an anti-inflammatory pain reliever and analgesic drug to treat rheumatoid arthritis and osteoarthritis under the brand Yingtaiqing. The companys products also comprise sustained release implants under the Sinofuan brand for the treatment of cancer; edaravone injection under the Yidasheng brand for the treatment of strokes; anti-diarrhea pharmaceutical under the Biqi brand; cefaclor in dry suspension antibiotics under the Zake brand for the treatment of infections; and a herbal medicine used for the treatment of coughs under the Simcere Kechuanning brand name. In addition, it distributes prescription pharmaceuticals manufactured by independent third parties, including generic alfacalcidol soft capsules under the name Faneng, and generic lentinan injection under the brand Yineng. As of March 31, 2009, it also had 12 product candidates in various stages of development, including treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea, and vomiting associated with chemotherapy. The company manufactures and sells 45 pharmaceuticals products and distributes 3 additional pharmaceuticals that are manufactured by independent third parties under the companys brand names. It has an agreement with Epitomics, Inc. for the co-development and production of humanized RabMAb antibody therapeutics for tumors. The company has a strategic partnership agreement with Sun Yat-Sen University Cancer Center. Simcere Pharmaceutical Group was founded in 1995 and is headquartered in Nanjing, the Peoples Republic of China. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Jinsheng Ren , 47
Co-Founder, Chairman and Chief Exec. officer |
N/A
| N/A | Mr. Zhigang Zhao , 48
Chief Financial Officer and Principal Accounting Officer |
N/A
| N/A | Mr. Jindong Zhou , 47
Exec. VP |
N/A
| N/A | Mr. Xiaojin Yin , 50
Sr. VP of R&D |
N/A
| N/A | Dr. Peng Wang Ph.D, 50
Chief Scientific Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.03% Nasdaq 
0.12 (1.28%) 
Profile
